March 26, 2024

Challenges of Medical Devices Registration in the EAEU

March 13, 2024

New Amendments in Federal Law “On Circulation of Medicines” in Russia

February 28, 2024

In Georgia, Pharmaceutical Companies That Have Not Provided a GMP Certificate are Facing New Risks

February 20, 2024

EAEU GMP Certificate is Mandatory

February 19, 2024

Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024

February 14, 2024

Key Contrasts in Georgia’s Registration Modes: National vs. Recognition

January 25, 2024

Pharmacovigilance Inspections in the EAEU: Key Changes and Preparation 

January 18, 2024

Enhancing Drug Safety: The Importance of Pharmacovigilance for Public Health

December 15, 2023

Summary of the TOPRA CEE Webinar: Regulatory Challenges in the CIS and Russia

November 30, 2023

QPPV in the CIS: Challenges and Opportunities

November 22, 2023

Regulatory Challenges in the CIS and Russia - TOPRA In CEE Webinar

November 01, 2023

Features of Choosing the Type of PIL RUT in EAEU

October 25, 2023

PIL Readability User Testing in EAEU Special Autumn Offer

February 15, 2022

PIL Readability Testing is Mandatory in EAEU

January 27, 2022

One More Inpharmatis Team Member Gets PhD in Pharmaceutical Sciences

January 18, 2022

Pharma 4.0: Data-Driven Regulation

January 05, 2022

New Inpharmatis Russian Office Phone Number

December 16, 2021

Inpharmatis Team Participated in the Russian Healthcare Forum

December 09, 2021

Inpharmatis Team Visited PharmTech & Ingredients Exhibition

December 07, 2021

QMS Dot Compliance Leaflet Available in Russian

November 17, 2021

Inpharmatis offers eCTDmanager leaflet in Russian

November 15, 2021

Automation in pharmaceutical manufacturing helps you comply with the new requirements of EAEU GMP Rules with minimal effort

November 11, 2021

Inpharmatis became the winner of the tender for PIL Readability User Testing according to the EAEU requirements for NPO “Microgen”

October 27, 2021

Optimizing Dossier Preparation in Accordance with EAEU Guidelines

October 18, 2021

Digital Technologies in Pharma Significantly Reduce the Risk of Cross-Contamination

September 28, 2021

Inpharmatis Head Office Moved to New Premises in Riga

September 07, 2021

Exclusive: Inpharmatis HR Director Lilita Brante on Pharma’s New Hiring Trends

July 21, 2021

Released a New Version of eCTDmanager 8.0 EXTEDO

July 20, 2021

New Inpharmatis Head office phone number

July 12, 2021

Inpharmatis Launched eQMS Dot Compliance Web Page in Russian

Challenges of Medical Devices Registration in the EAEU

March 26, 2024

New Amendments in Federal Law “On Circulation of Medicines” in Russia

March 13, 2024

In Georgia, Pharmaceutical Companies That Have Not Provided a GMP Certificate are Facing New Risks

February 28, 2024

EAEU GMP Certificate is Mandatory

February 20, 2024

Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024

February 19, 2024

Key Contrasts in Georgia’s Registration Modes: National vs. Recognition

February 14, 2024

Pharmacovigilance Inspections in the EAEU: Key Changes and Preparation 

January 25, 2024

Enhancing Drug Safety: The Importance of Pharmacovigilance for Public Health

January 18, 2024

Summary of the TOPRA CEE Webinar: Regulatory Challenges in the CIS and Russia

December 15, 2023

QPPV in the CIS: Challenges and Opportunities

November 30, 2023

Regulatory Challenges in the CIS and Russia - TOPRA In CEE Webinar

November 22, 2023

Features of Choosing the Type of PIL RUT in EAEU

November 01, 2023

PIL Readability User Testing in EAEU Special Autumn Offer

October 25, 2023

PIL Readability Testing is Mandatory in EAEU

February 15, 2022

One More Inpharmatis Team Member Gets PhD in Pharmaceutical Sciences

January 27, 2022

Pharma 4.0: Data-Driven Regulation

January 18, 2022

New Inpharmatis Russian Office Phone Number

January 05, 2022

Inpharmatis Team Participated in the Russian Healthcare Forum

December 16, 2021

Inpharmatis Team Visited PharmTech & Ingredients Exhibition

December 09, 2021

QMS Dot Compliance Leaflet Available in Russian

December 07, 2021

Inpharmatis offers eCTDmanager leaflet in Russian

November 17, 2021

Automation in pharmaceutical manufacturing helps you comply with the new requirements of EAEU GMP Rules with minimal effort

November 15, 2021

Inpharmatis became the winner of the tender for PIL Readability User Testing according to the EAEU requirements for NPO “Microgen”

November 11, 2021

Optimizing Dossier Preparation in Accordance with EAEU Guidelines

October 27, 2021

Digital Technologies in Pharma Significantly Reduce the Risk of Cross-Contamination

October 18, 2021

Inpharmatis Head Office Moved to New Premises in Riga

September 28, 2021

Exclusive: Inpharmatis HR Director Lilita Brante on Pharma’s New Hiring Trends

September 07, 2021

Released a New Version of eCTDmanager 8.0 EXTEDO

July 21, 2021

New Inpharmatis Head office phone number

July 20, 2021

Inpharmatis Launched eQMS Dot Compliance Web Page in Russian

July 12, 2021

Inpharmatis opened an official representative office in Tashkent

July 09, 2021

New Requirements for Medicine Registration in the EU Will Improve Global Data Exchange Between Pharmaceutical Companies and Regulators

June 14, 2021

Inpharmatis appoints new RA Director in Russia & CIS

May 31, 2021

Bringing the Dossier in Accordance With the Rules of the EAEU

May 27, 2021

Inpharmatis and “ACADEMPHARM” Discussed in Minsk Cooperation Opportunities

May 21, 2021

Participation in IPhEB Russia 2021

April 19, 2021

Participation in INNOPROM 2021 in Uzbekistan

April 12, 2021

Are You Ready for 2021 EAEU Regulatory Changes?

January 15, 2021

Webinar: EAEU Regulatory Challenges and Opportunities

November 09, 2020

Readability User Testing is Requested in EAEU

October 15, 2020

Inpharmatis & Epista Partnership Announcement

September 03, 2020

Inpharmatis Team COVID-19 Update

March 30, 2020

The EAEU Electronic Submission Format

November 20, 2019

Meet us at IV All-Russia GMP Conference 2019

September 23, 2019

eCTD and eCTDmanager in EAEU and CIS

July 23, 2019

eRA 2019 Conference with CIS Region Partner Meeting in Munich

June 02, 2019

Meet us at Conference RegLek EAEU 2019 in Moscow

April 15, 2019

Digital Pharma – Intelligent Pharmaceutical Enterprise in Kiev

April 12, 2019

Participation in DIA Europe 2019

April 01, 2019

Participation in the CPhI Worldwide 2018

November 30, 2018

eRA 2019 Conference

November 28, 2018

EMA Identifies Gaps in Industry Preparedness for Brexit

July 27, 2018

Russia and Bulgaria Signed Cooperation Agreement

July 27, 2018

EU and Japan Reinforce their Collaboration on Inspections of Medicine Manufacturers

July 20, 2018

Uzbekistan Admits Drug Registration from Countries with High Regulatory Requirements

July 02, 2018

Russian Pharmaceutical Forum 2018

May 21, 2018

Participation in DIA Global 2018

May 15, 2018

Inpharmatis office in Kiev

February 12, 2018

Celebrating Entrepreneurship at SLUSH

December 05, 2017

Join us at this years Regulatory Affairs Summit in Prague, 24-26 October, 2017

October 06, 2017

Thanks to all who participated in ERA 2017 event in Mallorca

July 27, 2017

Thanks to all who participated in Pharmacovigilance Strategy Course

May 11, 2017

eCTD format only! From January 1, 2021

May 02, 2017

European and US regulators agree on mutual recognition of inspections of medicines manufacturers

March 06, 2017

EXTEDO Announces New Regional Partnership with Inpharmatis for the Baltic and CIS region

February 09, 2017

Ukrainian government simplifies registration of medicines from the U.S., EU and certain other developed countries

January 16, 2017

New EU regulation on Medical devices, coming into force starting from 2017

January 16, 2017